Ledipasvir and sofosbuvir
HealthData.Gov
Updated Mar 25, 2026
About this dataset
Harvoni is a prescription medication by Gilead Sciences containing ledipasvir and sofosbuvir, used to treat chronic hepatitis C virus (HCV) infection in adults. It comes as oral pellets in strengths like 45 mg ledipasvir and 200 mg sofosbuvir per packet, taken once daily for 8-12 weeks depending on HCV genotype. It works by inhibiting HCV replication. Consult a doctor for proper use and side effects. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Ledipasvir and sofosbuvir
Access the FDA dataset for Ledipasvir and sofosbuvir β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025